Is GBS Stock a Buy Under $1?

Published on March 9, 2022

The shares of biosensor diagnostic technology company GBS’s (GBS) have slumped more than 50% in price this year, reflecting investors’ pessimism. The company’s weak financial position seems to be overshadowing...

Continue reading on website
Other news

Travel Insurance Might Not Cover COVID-19 — Unless You Upgrade 

March 9, 2022
When traveling during the COVID-19 era, it can make sense to have travel insurance. These days, trips have been canceled for all sorts of COVID-19-related reasons, beyond actual illness, such…

Acorns squirrels away $300M Series F after scrapping SPAC, now worth nearly $2B

March 9, 2022
Savings and investing app Acorns has raised $300 million in a Series F funding round that values the company at nearly $2 billion.The announcement of the raise comes about six weeks after the consumer fintech startup said it was shelving its plans for its $2.2 billion SPAC with Pioneer Merger Corp. in favor of an eventual traditional IPO. New York-based Acorns had last raised more than three years